{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:39:13Z","timestamp":1787319553305,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute on Drug AbuseNational Institute on Drug Abuse (NIDA)","award":["R01 DA013978"],"award-info":[{"award-number":["R01 DA013978"]}]},{"name":"R01","award":["DA023205"],"award-info":[{"award-number":["DA023205"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejmech.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T11:14:44Z","timestamp":1547032484000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Benzimidazolone-based selective \u03c32 receptor ligands: Synthesis and pharmacological evaluation"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-1745","authenticated-orcid":false,"given":"Sebastiano","family":"Intagliata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid F.","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Mesangeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seminerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Tong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae R.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.01.019_bib1","first-page":"517","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2019.01.019_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(83)90297-2","article-title":"Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog","volume":"92","author":"Vaupel","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib3","doi-asserted-by":"crossref","first-page":"pe12","DOI":"10.1126\/scisignal.261pe12","article-title":"When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor","volume":"2","author":"Su","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2019.01.019_bib4","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.01.019_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1996.1842","article-title":"Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)","volume":"229","author":"Kekuda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.01.019_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1471-4159.1998.70030922.x","article-title":"Cloning and functional characterization of a sigma receptor from rat brain","volume":"70","author":"Seth","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.01.019_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-2952(01)00666-9","article-title":"Molecular cloning and pharmacological characterization of the rat sigma1 receptor","volume":"62","author":"Mei","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","article-title":"A\u00a0proposal for the classification of sigma binding sites","volume":"13","author":"Quirion","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.01.019_bib10","first-page":"355","article-title":"Sigma receptors: biology and function","volume":"42","author":"Walker","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2019.01.019_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ncomms1386","article-title":"Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site","volume":"2","author":"Xu","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.01.019_bib12","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.ebiom.2015.10.017","article-title":"The sigma-2 receptor and progesterone receptor membrane component 1 are different binding sites derived from independent genes","volume":"2","author":"Chu","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2019.01.019_bib13","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the sigma2 receptor","volume":"114","author":"Alon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.01.019_bib14","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2174\/138161210793563365","article-title":"Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands","volume":"16","author":"van Waarde","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.01.019_bib15","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.01.019_bib16","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1054\/bjoc.1999.1067","article-title":"Sigma-2 receptors as a biomarker of proliferation in solid tumours","volume":"82","author":"Wheeler","year":"2000","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2019.01.019_bib17","series-title":"Sigma Receptor (sigmaR) Ligands with Antiproliferative and Anticancer Activity","first-page":"22","author":"Georgiadis","year":"2017"},{"key":"10.1016\/j.ejmech.2019.01.019_bib18","first-page":"313","article-title":"Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines","volume":"62","author":"Crawford","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.01.019_bib19","article-title":"Divergent cytotoxic and metabolically stimulative functions of sigma-2 receptors: structure-activity relationships of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) derivatives","author":"Nicholson","year":"2018","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2019.01.019_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-50174-1_1","article-title":"Introduction to sigma receptors: their role in disease and as therapeutic targets","volume":"964","author":"Smith","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-319-50174-1_10","article-title":"Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection","volume":"964","author":"Nguyen","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-50174-1_11","article-title":"Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders","volume":"964","author":"Albayrak","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-319-50174-1_14","article-title":"Stimulation of the sigma-1 receptor and the effects on neurogenesis and depressive behaviors in mice","volume":"964","author":"Fukunaga","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-50174-1_15","article-title":"Role of sigma1 receptors in learning and memory and alzheimer's disease-type dementia","volume":"964","author":"Maurice","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0031-6865(99)00034-5","article-title":"Sigma receptors: recent advances and new clinical potentials","volume":"74","author":"Bowen","year":"2000","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ejmech.2019.01.019_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-004-1920-9","article-title":"Sigma receptors: biology and therapeutic potential","volume":"174","author":"Guitart","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2019.01.019_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)00968-2","article-title":"Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice","volume":"419","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0028-3908(02)00056-4","article-title":"Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides","volume":"42","author":"Matsumoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.01.019_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(00)00917-1","article-title":"N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice","volume":"411","author":"Matsumoto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.019_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13321-017-0191-5","article-title":"S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands","volume":"9","author":"Nastasi","year":"2017","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2019.01.019_bib31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1021\/jm701357m","article-title":"Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity","volume":"51","author":"Mesangeau","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.019_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/jpet.109.161398","article-title":"A\u00a0novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice","volume":"333","author":"Xu","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2019.01.019_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuropharm.2011.06.028","article-title":"CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice","volume":"61","author":"Kaushal","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.01.019_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1208\/s12248-011-9274-9","article-title":"Synthesis and pharmacological evaluation of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents","volume":"13","author":"Kaushal","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2019.01.019_bib35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.euroneuro.2012.08.005","article-title":"Pharmacological evaluation of SN79, a sigma (\u03c3) receptor ligand, against methamphetamine-induced neurotoxicity in\u00a0vivo","volume":"23","author":"Kaushal","year":"2013","journal-title":"Eur. Neuropsychopharmacol. : the journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2019.01.019_bib36","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1016\/j.ejmech.2011.08.031","article-title":"Synthesis and pharmacological evaluation of indole-based sigma receptor ligands","volume":"46","author":"Mesangeau","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.019_bib37","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T01:33:46Z","timestamp":1552786426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S0223523419300297"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.019","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzimidazolone-based selective \u03c32 receptor ligands: Synthesis and pharmacological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}